What does CP-Endocrino do?

CP-Endocrino is a specialist medical practice in Overijse. Private Limited, started on 3 October 2023, 1 establishment.

What is the address of CP-Endocrino?

The registered office of CP-Endocrino is located at Memlingdreef 8, 3090 Overijse.

Is CP-Endocrino still active?

Yes. According to the CBE (31 October 2026) CP-Endocrino is active, legal situation “Normale toestand”, started on 3 October 2023.

Is CP-Endocrino registered on Peppol?

Yes, CP-Endocrino is registered on the Peppol network with ID 0208:1000641508.

What is the enterprise number of CP-Endocrino?

The enterprise number of CP-Endocrino is BE1000641508.

When was CP-Endocrino founded?

CP-Endocrino was founded on 3 October 2023.

Who are the directors of CP-Endocrino?

According to the 2025 annual accounts, the directors of CP-Endocrino are: Camille PAIRON.

Is CP-Endocrino a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 October 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CP-Endocrino make in 2025?

CP-Endocrino posted a profit after taxes of € 44,141 in financial year 2025.

What is the revenue of CP-Endocrino?

As a small company, CP-Endocrino is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 64,304.

CP-Endocrino (Private Limited) - Overijse - BE1000641508

Dossier CP-Endocrino, printed on 31 October 2026 from databakkes.be/en/1000641508/cp-endocrino. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CP-Endocrino from Overijse, company number BE1000641508, closed financial year 2025 with a result of € 44,141 after tax. For that financial year CP-Endocrino recorded a gross margin of € 64,304 and equity of € 118,160. Compared with financial year 2024, the result moved from € 58,481 to € 44,141. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Growing

€ 118,160

▲ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 44,141

▼ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 81,084

▲ 95% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 116,160.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 23,779

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 526

▲ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,627

▲ 85% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 17,257 Gross margin 2023: € 17,257 First fiscal year in the series	€ 80,388 Gross margin 2024: € 80,388 ▲ € 63,131 vs 2023 (€ 17,257) Favourable step	€ 64,304 Gross margin 2025: € 64,304 ▼ 20% vs 2024 (€ 80,388) Unfavourable step	▼ 20%
Profit after taxes	€ 13,538 Profit after taxes 2023: € 13,538 First fiscal year in the series	€ 58,481 Profit after taxes 2024: € 58,481 ▲ € 44,943 vs 2023 (€ 13,538) Favourable step	€ 44,141 Profit after taxes 2025: € 44,141 ▼ 25% vs 2024 (€ 58,481) Unfavourable step	▼ 25%
Equity	€ 15,538 Equity 2023: € 15,538 First fiscal year in the series	€ 74,019 Equity 2024: € 74,019 ▲ € 58,481 vs 2023 (€ 15,538) Favourable step	€ 118,160 Equity 2025: € 118,160 ▲ 60% vs 2024 (€ 74,019) Favourable step	▲ 60%
Total debts	€ 14,465 Total debts 2023: € 14,465 First fiscal year in the series	€ 3,198 Total debts 2024: € 3,198 ▼ 78% vs 2023 (€ 14,465) Favourable step	€ 5,153 Total debts 2025: € 5,153 ▲ 61% vs 2024 (€ 3,198) Unfavourable step	▲ 61%
Cash	€ 12,903 Cash 2023: € 12,903 First fiscal year in the series	€ 41,648 Cash 2024: € 41,648 ▲ 223% vs 2023 (€ 12,903) Favourable step	€ 81,084 Cash 2025: € 81,084 ▲ 95% vs 2024 (€ 41,648) Favourable step	▲ 95%
Retained profit	€ 13,538 Retained profit 2023: € 13,538 First fiscal year in the series	€ 72,019 Retained profit 2024: € 72,019 ▲ € 58,481 vs 2023 (€ 13,538) Favourable step	€ 116,160 Retained profit 2025: € 116,160 ▲ 61% vs 2024 (€ 72,019) Favourable step	▲ 61%
Balance sheet total	€ 30,003 Balance sheet total 2023: € 30,003 First fiscal year in the series	€ 77,217 Balance sheet total 2024: € 77,217 ▲ 157% vs 2023 (€ 30,003) Unchanged	€ 123,313 Balance sheet total 2025: € 123,313 ▲ 60% vs 2024 (€ 77,217) Unchanged	▲ 60%

Key figures of CP-Endocrino, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CP-Endocrino?

What happened at CP-Endocrino in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: profit of € 44,141 (▼ 25% vs 2024). Source: NBB ↗
Oct 3, 2023 New establishment in Overijse. KBO
Oct 3, 2023 Start of the company according to the CBE. KBO

In short

From € 13,538 profit in 2023 to € 44,141 profit in 2025.

Paid € 30,903 in corporate taxes since 2023.

Best year ever: 2024, with € 58,481 profit.

Original PDFs at the National Bank ↗

Management

Camille PAIRON

CP-Endocrino

Behind CP-Endocrino is Camille PAIRON.

Directors

According to the 2025 annual accounts

Camille PAIRON

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Memlingdreef 8

3090 Overijse

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

C-LOG Partners

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1000.641.508
VAT number: BE 1000.641.508
Registered office: Memlingdreef 8, 3090 Overijse
Names & denominations: CP-Endocrino
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 October 2023
Peppol: Active · Active since 11 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗